Sphingosine-1-phosphate modulates expression of vascular endothelial growth factor in human articular chondrocytes: A possible new role in arthritis

International Journal of Rheumatic Diseases

Volumn 15, Issue 4, 2012, Pages 366-373

  Masuko, Kayo ^a,b   Murata, Minako ^c   Beppu, Moroe ^a   Nakamura, Hiroshi ^d   Kato, Tomohiro ^a   Yudoh, Kazuo ^c  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SAGAMI WOMEN'S UNIVERSITY   (Japan)

^c University of Tokyo   (Japan)

^d NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Articular chondrocytes; ERK MAPK; Osteoarthritis; S1P; VEGF

Indexed keywords

SPHINGOSINE 1 PHOSPHATE; VASCULOTROPIN;

AGED; ARTHRITIS; ARTICLE; CARTILAGE CELL; FEMALE; HUMAN; HUMAN CELL; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

AGED; CARTILAGE, ARTICULAR; CELLS, CULTURED; CHONDROCYTES; DRUG INTERACTIONS; ENZYME INHIBITORS; FEMALE; FLAVONOIDS; GENE EXPRESSION; HUMANS; IMIDAZOLES; IMMUNOSUPPRESSIVE AGENTS; LYSOPHOSPHOLIPIDS; MALE; MITOGEN-ACTIVATED PROTEIN KINASES; OSTEOARTHRITIS; PERTUSSIS TOXIN; PROPYLENE GLYCOLS; PYRIDINES; RNA, MESSENGER; SPHINGOSINE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84865297437     PISSN: 17561841     EISSN: 1756185X     Source Type: Journal    
DOI: 10.1111/j.1756-185X.2012.01756.x     Document Type: Article

References (45)

1. Spiegel S, Milstien S (2002) Sphingosine 1-phosphate, a key cell signaling molecule. J Biol Chem 277, 25851-4.
2. Yang L, Yatomi Y, Miura Y, Satoh K, Ozaki Y (1999) Metabolism and functional effects of sphingolipids in blood cells. Br J Haematol 107, 282-93.
3. Yatomi Y, Igarashi Y, Yang L et al. (1997) Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum. J Biochem 121, 969-73.
4. Payne SG, Milstien S, Spiegel S (2002) Sphingosine-1-phosphate: dual messenger functions. FEBS Lett 531, 54-7.
5. Rivera J, Proia RL, Olivera A (2008) The alliance of sphingosine-1-phosphate and its receptors in immunity. Nat Rev Immunol 8, 753-63.
6. Kitano M, Hla T, Sekiguchi M et al. (2006) Sphingosine 1-phosphate/sphingosine 1-phosphate receptor 1 signaling in rheumatoid synovium: regulation of synovial proliferation and inflammatory gene expression. Arthritis Rheum 54, 742-53.
7. Masuko K, Murata M, Nakamura H et al. (2007) Sphingosine-1-phosphate attenuates proteoglycan aggrecan expression via production of prostaglandin E2 from human articular chondrocytes. BMC Musculoskelet Disord 8, 29.
8. Bayless KJ, Davis GE (2003) Sphingosine-1-phosphate markedly induces matrix metalloproteinase and integrin-dependent human endothelial cell invasion and lumen formation in three-dimensional collagen and fibrin matrices. Biochem Biophys Res Commun 312, 903-13.
9. Lai WQ, Irwan AW, Goh HH et al. (2008) Anti-inflammatory effects of sphingosine kinase modulation in inflammatory arthritis. J Immunol 181, 8010-7.
10. Murata M, Yudoh K, Masuko K (2008) The potential role of vascular endothelial growth factor (VEGF) in cartilage: how the angiogenic factor could be involved in the pathogenesis of osteoarthritis? Osteoarthritis Cart 16, 279-86.
11. Shibakawa A, Yudoh K, Masuko-Hongo K et al. (2005) The role of subchondral bone resorption pits in osteoarthritis: MMP production by cells derived from bone marrow. Osteoarthritis Cart 13, 679-87.
12. Enomoto H, Inoki I, Komiya K et al. (2003) Vascular endothelial growth factor isoforms and their receptors are expressed in human osteoarthritic cartilage. Am J Pathol 162, 171-81.
13. Inoue K, Masuko-Hongo K, Okamoto M, Nishioka K (2005) Induction of vascular endothelial growth factor and matrix metalloproteinase-3 (stromelysin) by interleukin-1 in human articular chondrocytes and synoviocytes. Rheumatol Int, 93-8.
14. Murata M, Yudoh K, Nakamura H et al. (2006) Distinct signaling pathways are involved in hypoxia- and IL-1-induced VEGF expression in human articular chondrocytes. J Orthop Res 24, 1544-54.
15. Honorati MC, Cattini L, Facchini A (2004) IL-17, IL-1beta and TNF-alpha stimulate VEGF production by dedifferentiated chondrocytes. Osteoarthritis Cart 12, 683-91.
16. Honorati MC, Cattini L, Facchini A (2007) VEGF production by osteoarthritic chondrocytes cultured in micromass and stimulated by IL-17 and TNF-alpha. Connect Tissue Res 48, 239-45.
17. Pufe T, Lemke A, Kurz B et al. (2004) Mechanical overload induces VEGF in cartilage discs via hypoxia-inducible factor. Am J Pathol 164, 185-92.
18. Lin C, McGough R, Aswad B, Block JA, Terek R (2004) Hypoxia induces HIF-1alpha and VEGF expression in chondrosarcoma cells and chondrocytes. J Orthop Res 22, 1175-81.
19. Yonesu K, Kawase Y, Inoue T et al. (2009) Involvement of sphingosine-1-phosphate and S1P1 in angiogenesis: analyses using a new S1P1 antagonist of non-sphingosine-1-phosphate analog. Biochem Pharmacol 77, 1011-20.
20. Heo K, Park KA, Kim YH et al. (2009) Sphingosine 1-phosphate induces vascular endothelial growth factor expression in endothelial cells. BMB Rep 42, 685-90.
21. Sun HY, Wei SP, Xu RC, Xu PX, Zhang WC (2010) Sphingosine-1-phosphate induces human endothelial VEGF and MMP-2 production via transcription factor ZNF580: novel insights into angiogenesis. Biochem Biophys Res Commun 395, 361-6.
22. Skoura A, Sanchez T, Claffey K et al. (2007) Essential role of sphingosine 1-phosphate receptor 2 in pathological angiogenesis of the mouse retina. J Clin Invest 117, 2506-16.
23. Caballero S, Swaney J, Moreno K et al. (2009) Anti-sphingosine-1-phosphate monoclonal antibodies inhibit angiogenesis and sub-retinal fibrosis in a murine model of laser-induced choroidal neovascularization. Exp Eye Res 88, 367-77.
24. Xie B, Shen J, Dong A et al. (2009) Blockade of sphingosine-1-phosphate reduces macrophage influx and retinal and choroidal neovascularization. J Cell Physiol 218, 192-8.
25. Swaney JS, Moreno KM, Gentile AM, Sabbadini RA, Stoller GL (2008) Sphingosine-1-phosphate (S1P) is a novel fibrotic mediator in the eye. Exp Eye Res 87, 367-75.
26. Li C, Jiang X, Yang L et al. (2009) Involvement of sphingosine 1-phosphate (SIP)/S1P3 signaling in cholestasis-induced liver fibrosis. Am J Pathol 175, 1464-72.
27. Bu S, Asano Y, Bujor A et al. (2010) Dihydrosphingosine 1-phosphate has a potent antifibrotic effect in scleroderma fibroblasts via normalization of phosphatase and tensin homolog levels. Arthritis Rheum 62, 2117-26.
28. Ray A, Ray BK (2008) An inflammation-responsive transcription factor in the pathophysiology of osteoarthritis. Biorheology 45(3-4), 39, 9-409.
29. Kellgren JH, Lawrence JS (1957) Radiological assessment of osteo-arthrosis. Ann Rheum Dis 16, 494-502.
30. Lee OH, Kim YM, Lee YM et al. (1999) Sphingosine 1-phosphate induces angiogenesis: its angiogenic action and signaling mechanism in human umbilical vein endothelial cells. Biochem Biophys Res Commun 264, 743-50.
31. Duan HF, Wu CT, Lu Y et al. (2004) Sphingosine kinase activation regulates hepatocyte growth factor induced migration of endothelial cells. Exp Cell Res 298, 593-601.
32. Lai WQ, Irwan AW, Goh HH et al. (2009) Distinct roles of sphingosine kinase 1 and 2 in murine collagen-induced arthritis. J Immunol 183, 2097-103.
33. Hashimoto S, Creighton-Achermann L, Takahashi K et al. (2002) Development and regulation of osteophyte formation during experimental osteoarthritis. Osteoarthritis Cartilage 10, 180-7.
34. Pufe T, Harde V, Petersen W et al. (2004) Vascular endothelial growth factor (VEGF) induces matrix metalloproteinase expression in immortalized chondrocytes. J Pathol 202, 367-74.
35. Bonnet CS, Walsh DA (2005) Osteoarthritis, angiogenesis and inflammation. Rheumatology (Oxford) 44, 7-16.
36. Ashraf S, Walsh DA (2008) Angiogenesis in osteoarthritis. Curr Opin Rheumatol 20, 573-80.
37. Tanaka E, Aoyama J, Miyauchi M et al. (2005) Vascular endothelial growth factor plays an important autocrine/paracrine role in the progression of osteoarthritis. Histochem Cell Biol 123(3), 275-81.
38. Gaudry M, Bregerie O, Andrieu V et al. (1997) Intracellular pool of vascular endothelial growth factor in human neutrophils. Blood 90, 4153-61.
39. Valter MM, Wiestler OD, Pietsche T (1999) Differential control of VEGF synthesis and secretion in human glioma cells by IL-1 and EGF. Int J Dev Neurosci 17(5-6), 56, 5-77.
40. Brinkmann V (2007) Sphingosine 1-phosphate receptors in health and disease: mechanistic insights from gene deletion studies and reverse pharmacology. Pharmacol Ther 115, 84-105.
41. Chiba K (2005) FTY720, a new class of immunomodulator, inhibits lymphocyte egress from secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors. Pharmacol Ther 108, 308-19.
42. Brinkmann V, Cyster JG, Hla T (2004) FTY720: sphingosine 1-phosphate receptor-1 in the control of lymphocyte egress and endothelial barrier function. Am J Transplant 4, 1019-25.
43. Okajima E, Thorgeirsson UP (2000) Different regulation of vascular endothelial growth factor expression by the ERK and p38 kinase pathways in v-ras, v-raf, and v-myc transformed cells. Biochem Biophys Res Commun 270, 108-11.
44. Giuliani N, Lunghi P, Morandi F et al. (2004) Downmodulation of ERK protein kinase activity inhibits VEGF secretion by human myeloma cells and myeloma-induced angiogenesis. Leukemia 18, 628-35.
45. Zhou H, Murthy KS (2004) Distinctive G protein-dependent signaling in smooth muscle by sphingosine 1-phosphate receptors S1P1 and S1P2. Am J Physiol Cell Physiol 286, C1130-8.